vs
Side-by-side financial comparison of Automatic Data Processing (ADP) and Bausch Health Companies Inc. (BHC). Click either name above to swap in a different company.
Automatic Data Processing is the larger business by last-quarter revenue ($5.4B vs $2.8B, roughly 1.9× Bausch Health Companies Inc.). Automatic Data Processing runs the higher net margin — 19.8% vs -3.7%, a 23.5% gap on every dollar of revenue. On growth, Bausch Health Companies Inc. posted the faster year-over-year revenue change (9.3% vs 6.2%). Over the past eight quarters, Bausch Health Companies Inc.'s revenue compounded faster (14.0% CAGR vs 1.0%).
Automatic Data Processing, Inc. (ADP) is an American multinational provider of cloud-based human resources management, payroll processing, and professional employer organization (PEO) services, headquartered in Roseland, New Jersey.
Bausch Health Companies Inc. is a global, diversified American-Canadian pharmaceutical company. Its global corporate headquarters are located in Laval, Quebec, Canada, and its U.S. headquarters are in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neurology, dermatology, dentistry, medical aesthetics, and international pharmaceuticals. Bausch Health manufactures and markets branded pharmaceuticals, generic ph...
ADP vs BHC — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.4B | $2.8B |
| Net Profit | $1.1B | $-103.0M |
| Gross Margin | 46.1% | — |
| Operating Margin | 25.8% | 17.0% |
| Net Margin | 19.8% | -3.7% |
| Revenue YoY | 6.2% | 9.3% |
| Net Profit YoY | 10.3% | -205.1% |
| EPS (diluted) | $2.62 | $-0.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.4B | $2.8B | ||
| Q3 25 | $5.2B | $2.7B | ||
| Q2 25 | $5.1B | $2.5B | ||
| Q1 25 | $5.6B | $2.3B | ||
| Q4 24 | $5.0B | $2.6B | ||
| Q3 24 | $4.8B | $2.5B | ||
| Q2 24 | $4.8B | $2.4B | ||
| Q1 24 | $5.3B | $2.2B |
| Q4 25 | $1.1B | $-103.0M | ||
| Q3 25 | $1.0B | $179.0M | ||
| Q2 25 | $910.7M | $148.0M | ||
| Q1 25 | $1.2B | $-58.0M | ||
| Q4 24 | $963.2M | $98.0M | ||
| Q3 24 | $956.3M | $-85.0M | ||
| Q2 24 | $829.3M | $10.0M | ||
| Q1 24 | $1.2B | $-64.0M |
| Q4 25 | 46.1% | — | ||
| Q3 25 | 45.2% | — | ||
| Q2 25 | 45.1% | — | ||
| Q1 25 | 47.7% | — | ||
| Q4 24 | 45.7% | — | ||
| Q3 24 | 45.5% | — | ||
| Q2 24 | 44.8% | — | ||
| Q1 24 | 47.3% | — |
| Q4 25 | 25.8% | 17.0% | ||
| Q3 25 | 25.3% | 23.1% | ||
| Q2 25 | 23.2% | 17.5% | ||
| Q1 25 | 29.2% | 12.2% | ||
| Q4 24 | 25.0% | 21.8% | ||
| Q3 24 | 25.6% | 12.7% | ||
| Q2 24 | 22.8% | 16.2% | ||
| Q1 24 | 29.4% | 13.1% |
| Q4 25 | 19.8% | -3.7% | ||
| Q3 25 | 19.6% | 6.7% | ||
| Q2 25 | 17.8% | 5.8% | ||
| Q1 25 | 22.5% | -2.6% | ||
| Q4 24 | 19.1% | 3.8% | ||
| Q3 24 | 19.8% | -3.4% | ||
| Q2 24 | 17.4% | 0.4% | ||
| Q1 24 | 22.6% | -3.0% |
| Q4 25 | $2.62 | $-0.30 | ||
| Q3 25 | $2.49 | $0.48 | ||
| Q2 25 | $2.23 | $0.40 | ||
| Q1 25 | $3.06 | $-0.16 | ||
| Q4 24 | $2.35 | $0.24 | ||
| Q3 24 | $2.34 | $-0.23 | ||
| Q2 24 | $2.01 | $0.03 | ||
| Q1 24 | $2.88 | $-0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.5B | $1.3B |
| Total DebtLower is stronger | — | $20.8B |
| Stockholders' EquityBook value | $6.4B | $-554.0M |
| Total Assets | $84.6B | $26.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.5B | $1.3B | ||
| Q3 25 | $7.9B | $1.3B | ||
| Q2 25 | $7.8B | $1.7B | ||
| Q1 25 | $2.7B | $1.1B | ||
| Q4 24 | $2.2B | $1.2B | ||
| Q3 24 | $7.3B | $719.0M | ||
| Q2 24 | $3.3B | $595.0M | ||
| Q1 24 | $3.3B | $733.0M |
| Q4 25 | — | $20.8B | ||
| Q3 25 | — | $21.0B | ||
| Q2 25 | — | $21.7B | ||
| Q1 25 | — | $21.5B | ||
| Q4 24 | — | $21.6B | ||
| Q3 24 | — | $21.5B | ||
| Q2 24 | — | $21.7B | ||
| Q1 24 | — | $22.1B |
| Q4 25 | $6.4B | $-554.0M | ||
| Q3 25 | $6.4B | $-565.0M | ||
| Q2 25 | $6.2B | $-764.0M | ||
| Q1 25 | $5.9B | $-1.2B | ||
| Q4 24 | $5.1B | $-1.3B | ||
| Q3 24 | $5.3B | $-1.2B | ||
| Q2 24 | $4.5B | $-1.2B | ||
| Q1 24 | $4.6B | $-1.1B |
| Q4 25 | $84.6B | $26.4B | ||
| Q3 25 | $54.3B | $26.8B | ||
| Q2 25 | $53.4B | $27.3B | ||
| Q1 25 | $56.4B | $26.4B | ||
| Q4 24 | $64.1B | $26.5B | ||
| Q3 24 | $49.5B | $26.5B | ||
| Q2 24 | $54.4B | $26.5B | ||
| Q1 24 | $64.2B | $26.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.1B | $495.0M |
| Free Cash FlowOCF − Capex | — | $403.0M |
| FCF MarginFCF / Revenue | — | 14.4% |
| Capex IntensityCapex / Revenue | — | 3.3% |
| Cash ConversionOCF / Net Profit | 1.07× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.0B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.1B | $495.0M | ||
| Q3 25 | $642.3M | $405.0M | ||
| Q2 25 | $1.4B | $289.0M | ||
| Q1 25 | $1.5B | $211.0M | ||
| Q4 24 | $1.2B | $601.0M | ||
| Q3 24 | $824.4M | $405.0M | ||
| Q2 24 | $1.3B | $380.0M | ||
| Q1 24 | $1.5B | $211.0M |
| Q4 25 | — | $403.0M | ||
| Q3 25 | — | $314.0M | ||
| Q2 25 | — | $190.0M | ||
| Q1 25 | — | $96.0M | ||
| Q4 24 | — | $495.0M | ||
| Q3 24 | — | $334.0M | ||
| Q2 24 | — | $302.0M | ||
| Q1 24 | — | $129.0M |
| Q4 25 | — | 14.4% | ||
| Q3 25 | — | 11.7% | ||
| Q2 25 | — | 7.5% | ||
| Q1 25 | — | 4.2% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | — | 13.3% | ||
| Q2 24 | — | 12.6% | ||
| Q1 24 | — | 6.0% |
| Q4 25 | — | 3.3% | ||
| Q3 25 | — | 3.4% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 5.1% | ||
| Q4 24 | — | 4.1% | ||
| Q3 24 | — | 2.8% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 3.8% |
| Q4 25 | 1.07× | — | ||
| Q3 25 | 0.63× | 2.26× | ||
| Q2 25 | 1.58× | 1.95× | ||
| Q1 25 | 1.22× | — | ||
| Q4 24 | 1.19× | 6.13× | ||
| Q3 24 | 0.86× | — | ||
| Q2 24 | 1.57× | 38.00× | ||
| Q1 24 | 1.26× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ADP
| HCM | $2.2B | 42% |
| PEO Zero Margin Benefits Pass Throughs | $1.1B | 21% |
| HRO | $979.3M | 18% |
| Global | $709.3M | 13% |
| Interest On Funds Held For Clients | $308.6M | 6% |
BHC
| Bausch Lomb | $1.4B | 50% |
| Salix Segment | $693.0M | 25% |
| International Rx | $306.0M | 11% |
| Diversified Segment | $255.0M | 9% |
| Solta Medical Segment | $137.0M | 5% |
